Actively Recruiting
Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion: A Multihospital Study
Led by National Taiwan University Hospital · Updated on 2025-06-22
2000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate how artificial intelligence (AI) can help diagnose Helicobacter pylori infection and premalignant gastric lesions by analyzing upper endoscopic images. The study focuses on linking these images with urea breath test results and histopathological findings to improve diagnosis accuracy. The goal is to support clinicians, especially in rural areas, through a telemedicine system that assists in detecting these conditions and potentially links to gastric cancer risk. Participants undergo urea breath tests, upper gastrointestinal endoscopy, and histology examinations. The AI analyzes the correlation between the collected endoscopic images and the test results. This approach will be developed into a telemedicine service to assist healthcare providers in remote locations, such as the Matsu Islands. Throughout the study, researchers collect and review test results, endoscopic images, and histopathological data. They will measure how sensitive the AI is in detecting premalignant gastric lesions over up to five years and assess its ability to accurately exclude these conditions. The study runs until the end of 2026, allowing long-term follow-up and evaluation of the AI system's diagnostic performance.
CONDITIONS
Brief Title
Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 20 and 80 years
- Scheduled to undergo urea breath test and upper gastrointestinal endoscopy
You will not qualify if you...
- History of gastric surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 1 day
Participants undergo urea breath test, upper gastrointestinal endoscopy, and histology examination to collect diagnostic data.
1 visit (in-person)
Duration - Up to 5 years
Participants' diagnostic results and endoscopic images are monitored to analyze the correlation and assist in diagnosing Helicobacter pylori infection and detecting premalignant gastric lesions.
Trial Site Locations
Total: 1 location
1
Yi-Chia Lee
Taipei, Taiwan, 10015
Actively Recruiting
Research Team
Y
Yi-Chia Lee, MD, PhD
T
Tsung-Hsien Chiang, MD,PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here